Promising biomarkers for predicting the outcomes of patients with<i>KRAS</i>wild-type metastatic colorectal cancer treated with anti-epidermal growth factor receptor monoclonal antibodies: A systematic review with meta-analysis
Distribution of the number of citations over years.